Abstract | BACKGROUND: Injection with botulinum A exotoxin reconstituted with preserved saline has been shown to be less uncomfortable than injection with the same toxin reconstituted with preservative-free saline. OBJECTIVE: We sought to determine whether injection with botulinum toxin type B is similarly less painful when preservative-containing saline is used to further dilute the product. METHODS: We conducted a double-blind, randomized controlled trial. A total of 15 consecutive adult patients presenting for treatment of upper face dynamic lines received treatment to one side (left or right) of the face with toxin type B further diluted with preservative-containing saline, and to the other side with toxin type B further diluted with preservative-free saline. RESULTS: Of 15 patients, 13 (87%) reported less pain in the halves of their faces treated with the preservative-containing saline (P =.0006). Pain on the preservative-containing side was on average 32% less among patients as a whole, and 39% less among patients noting some reduction. The 95% confidence interval for pain reduction associated with preservative-containing injection was -46.9% to -16.1%. Neither investigators nor patients observed any difference in clinical efficacy between the 2 treatment sides. CONCLUSIONS: Use of preservative-containing saline to further dilute botulinum toxin type B can significantly decrease patient discomfort on injection.
|
Authors | S van Laborde, Jeffrey S Dover, Megan Moore, Brigitte Stewart, Kenneth A Arndt, Murad Alam |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 48
Issue 6
Pg. 875-7
(Jun 2003)
ISSN: 0190-9622 [Print] United States |
PMID | 12789177
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Preservatives, Pharmaceutical
- rimabotulinumtoxinB
- Sodium Chloride
- Metalloendopeptidases
- Botulinum Toxins
- Botulinum Toxins, Type A
|
Topics |
- Botulinum Toxins
(administration & dosage)
- Botulinum Toxins, Type A
- Double-Blind Method
- Female
- Humans
- Injections
(adverse effects)
- Male
- Metalloendopeptidases
(administration & dosage)
- Middle Aged
- Pain
(prevention & control)
- Preservatives, Pharmaceutical
- Prospective Studies
- Sodium Chloride
|